An introduction to 3D bioprinting – and how it will change your life
Chief Scientific Officer, Aspect Biosystems
Sam Wadsworth, Ph.D., Chief Scientific Officer & Co-Founder Aspect Biosystems. Sam is a world leader in the field of human airway tissue engineering and has published many peer-reviewed papers on related research. After completing his Ph.D. in respiratory cell biology in the UK, Sam moved to Vancouver, BC for a Post-Doc at the UBC Centre for Heart + Lung Innovation at St. Paul’s Hospital, where he spearheaded an inter-disciplinary, cross-Canada research project to build living 3-Dimensional human airway tissues. In 2013 Sam co-founded Aspect Biosystems with Konrad Walus, Simon Beyer and Tamer Mohamed. Aspect is a tissue engineering company with proprietary 3D-bioprinting technology capable of fabricating a variety of physiologically-relevant human tissues. Sam will be discussing Aspect’s unique technology, and will describe how 3D bioprinting has the potential to revolutionise the fields of pharmaceutical drug development, disease research, personalised and regenerative medicine by providing living human tissues on demand.